|
|
|
|
As from January 2, 2015 the following companies will change segment at Nasdaq Nordic. |
|
|
|
|
|
|
|
|
Exchange |
Orderbook Code |
Issuer Long Name |
ISIN |
Current Segment |
New List |
XSTO |
AERO B |
Aerocrine AB ser B |
SE0000434292 |
Mid Cap |
Small Cap |
XSTO |
BETS B |
Betsson AB ser B |
SE0005936911 |
Mid Cap |
Large Cap |
XSTO |
BALD B |
Fastighets AB Balder ser B |
SE0000455057 |
Mid Cap |
Large Cap |
XSTO |
BALD PREF |
Fastighets AB Balder pref |
SE0003949973 |
Mid Cap |
Large Cap |
XSTO |
BEF SDB |
Black Earth Farming Ltd. SDB |
SE0001882291 |
Mid Cap |
Small Cap |
XSTO |
HMS |
HMS Networks AB |
SE0002136242 |
Small Cap |
Mid Cap |
XSTO |
INDT |
Indutrade AB |
SE0001515552 |
Mid Cap |
Large Cap |
XSTO |
LIFCO B |
Lifco AB ser B |
SE0006370730 |
Mid Cap |
Large Cap |
XSTO |
LOOM B |
Loomis AB ser B |
SE0002683557 |
Mid Cap |
Large Cap |
XSTO |
MYCR |
Mycronic AB |
SE0000375115 |
Small Cap |
Mid Cap |
XSTO |
NOBI |
Nobia AB |
SE0000949331 |
Mid Cap |
Large Cap |
XSTO |
OASM |
Oasmia Pharmaceutical AB |
SE0000722365 |
Small Cap |
Mid Cap |
XSTO |
TWW |
Transcom WorldWide AB |
SE0006055257 |
Small Cap |
Mid Cap |
XSTO |
VBG B |
VBG GROUP AB ser B |
SE0000115107 |
Small Cap |
Mid Cap |
XSTO |
VITR |
Vitrolife AB |
SE0000816043 |
Small Cap |
Mid Cap |
|
|
|
|
|
|
|
|
|
|
|
|
XHEL |
BTH1V |
Biotie Therapies Oyj |
FI0009011571 |
Mid Cap |
Small Cap |
XHEL |
CTY1S |
Citycon Oyj |
FI0009002471 |
Mid Cap |
Large Cap |
XHEL |
SDA1V |
Sponda Oyj |
FI0009006829 |
Mid Cap |
Large Cap |
XHEL |
STCAS |
Stockmann Oyj Abp A |
FI0009000236 |
Large Cap |
Mid Cap |
XHEL |
STCBV |
Stockmann Oyj Abp B |
FI0009000251 |
Large Cap |
Mid Cap |
XHEL |
TLV1V |
Talvivaaran Kaivososakeyhtiö Oyj |
FI0009014716 |
Mid Cap |
Small Cap |
|
|
|
|
|
|
|
|
|
|
|
|
XCSE |
EAC |
Det Østasiatiske Kompagni A/S |
DK0010006329 |
Mid Cap |
Small Cap |
XCSE |
NRSU |
Nørresundby Bank A/S |
DK0060135549 |
Small Cap |
Mid Cap |
XCSE |
PAAL B |
Per Aarsleff B A/S |
DK0010243450 |
Small Cap |
Mid Cap |
XCSE |
RBREW |
Royal UNIBREW A/S |
DK0010242999 |
Mid Cap |
Large Cap |
XCSE |
VELO |
Veloxis Pharmaceuticals A/S |
DK0060048148 |
Small Cap |
Mid Cap |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The segment Large Cap includes companies whose shares have a market value of 1 |
|
|
|
billion euro or more. In the segment Mid Cap companies whose shares have a |
|
|
|
market value between 150 million euro and 1 billion euro are included and the |
|
|
|
segment Small Cap includes companies whose shares have a market value of less |
|
|
|
than 150 millon euro. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The next market cap-segment revision will take effect in January 2016 based on market |
|
|
|
value in November 2015. |
|
|
|
|
|
|
|
|
|
|
For further information concerning this exchange notice please call Corporate Client Group or Market Research, telephone
+ 46 8 405 60 00. |
|
|
|
|
|
|
|
|
|
|
|
|
|
NASDAQ OMX Stockholm AB |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|